Genomic analysis of LPS-stimulated myeloid cells identifies a common pro-inflammatory response but divergent IL-10 anti-inflammatory responses

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Hutchins, Andrew Paul ^a,b   Takahashi, Yoshiko ^b,c   Miranda Saavedra, Diego ^b,d,e  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^b OSAKA UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e IE BUSINESS SCHOOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CYTOKINE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; STAT3 PROTEIN;

ANTIBODY SPECIFICITY; BONE MARROW CELL; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; HUMAN; IMMUNOLOGY; INFLAMMATION; LEUKOCYTE; MACROPHAGE; METABOLISM;

CLUSTER ANALYSIS; CYTOKINES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOMICS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-10; LEUKOCYTES; LIPOPOLYSACCHARIDES; MACROPHAGES; MYELOID CELLS; ORGAN SPECIFICITY; STAT3 TRANSCRIPTION FACTOR;

EID: 84924777822     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09100     Document Type: Article

References (60)

1. Cohen, J. The immunopathogenesis of sepsis. Nature 420, 885-891, doi:10.1038/nature01326 (2002).
2. Tan, Y. & Kagan, J. C. A cross-disciplinary perspective on the innate immune responses to bacterial lipopolysaccharide. Mol Cell 54, 212-223, doi:10.1016/j.molcel.2014.03.012 (2014).
3. Medzhitov, R. Origin and physiological roles of inflammation. Nature 454, 428-435, doi:10.1038/nature07201 (2008).
4. Murray, P. J. & Smale, S. T. Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways. Nature immunology 13, 916-924, doi:10.1038/ni.2391 (2012).
5. Banchereau, J., Pascual, V. & O'Garra, A. From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines. Nature immunology 13, 925-931, doi:10.1038/ni.2406 (2012).
6. Hutchins, A. P., Diez, D. & Miranda-Saavedra, D. The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challenges. Briefings in functional genomics 12, 489-498, doi:10.1093/bfgp/elt028 (2013).
7. Fiorentino, D. F., Bond, M. W. & Mosmann, T. R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. The Journal of experimental medicine 170, 2081-2095 (1989).
8. Saraiva, M. & O'Garra, A. The regulation of IL-10 production by immune cells. Nature reviews. Immunology 10, 170-181, doi:10.1038/nri2711 (2010).
9. MacKenzie, K. F., Pattison, M. J.&Arthur, J. S. Transcriptional regulation of IL-10 and its cell-specific role in vivo. Crit Rev Immunol 34, 315-345, doi:0aa7e636021d59df (2014).
10. Carey, A. J., Tan, C. & Ulett, G. Infection-induced IL-10 and JAK-STAT: A review of the molecular circuitry controlling immune hyperactivity in response to pathogenic microbes. JAK-STAT 1, 159-167 (2012).
11. Couper, K. N., Blount, D. G. & Riley, E. M. IL-10: the master regulator of immunity to infection. J Immunol 180, 5771-5777 (2008).
12. Beamer, G. L. et al. Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. J Immunol 181, 5545-5550 (2008).
13. Kane, M. M. &Mosser, D. M. The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol 166, 1141-1147 (2001).
14. Yamamoto, M. et al. A single polymorphic amino acid on Toxoplasma gondii kinase ROP16 determines the direct and strain-specific activation of Stat3. The Journal of experimental medicine 206, 2747-2760, doi:10.1084/jem.20091703 (2009).
15. Butcher, B. A. et al. IL-10-independent STAT3 activation by Toxoplasma gondii mediates suppression of IL-12 and TNF-alpha in host macrophages. J Immunol 174, 3148-3152 (2005).
16. Brooks, D. G. et al. Interleukin-10 determines viral clearance or persistence in vivo. Nature medicine 12, 1301-1309, doi:10.1038/nm1492 (2006).
17. Brockman, M. A. et al. IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 114, 346-356, doi:10.1182/blood-2008-12-191296 (2009).
18. Kotenko, S. V., Saccani, S., Izotova, L. S., Mirochnitchenko, O. V. & Pestka, S. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proceedings of the National Academy of Sciences of the United States of America 97, 1695-1700 (2000).
19. Liu, Y. et al. The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. J Immunol 158, 604-613 (1997).
20. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274 (1993).
21. Glocker, E. O. et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. The New England journal of medicine 361, 2033-2045, doi:10.1056/NEJMoa0907206 (2009).
22. Akdis, C. A. & Blaser, K. Mechanisms of interleukin-10-mediated immune suppression. Immunology 103, 131-136 (2001).
23. Takeda, K. et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10, 39-49 (1999).
24. Cassatella, M. A. et al. Lipopolysaccharide primes neutrophils for a rapid response to IL-10. European journal of immunology 35, 1877-1885, doi:10.1002/eji.200526088 (2005).
25. Dang, P. M. et al. Anti-inflammatory effect of interleukin-10 on human neutrophil respiratory burst involves inhibition of GM-CSF-induced p47PHOX phosphorylation through a decrease in ERK1/2 activity. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 20, 1504-1506, doi:10.1096/fj.05-5395fje (2006).
26. Marshall, J. S., Leal-Berumen, I., Nielsen, L., Glibetic, M. & Jordana, M. Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. The Journal of clinical investigation 97, 1122-1128, doi:10.1172/JCI118506 (1996).
27. Takanaski, S. et al. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. The Journal of experimental medicine 180, 711-715 (1994).
28. Grutz, G. New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. Journal of leukocyte biology 77, 3-15, doi:10.1189/jlb.0904484 (2005).
29. al-Shami, A., Bourgoin, S. G. & Naccache, P. H. Granulocyte-macrophage colonystimulating factor-activated signaling pathways in human neutrophils. I. Tyrosine phosphorylation-dependent stimulation of phosphatidylinositol 3-kinase and inhibition by phorbol esters. Blood 89, 1035-1044 (1997).
30. Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC bioinformatics 9, 559, doi:10.1186/1471-2105-9-559 (2008).
31. Lang, R., Patel, D., Morris, J. J., Rutschman, R. L. & Murray, P. J. Shaping gene expression in activated and resting primary macrophages by IL-10. J Immunol 169, 2253-2263 (2002).
32. Bhatt, D. M. et al. Transcript dynamics of proinflammatory genes revealed by sequence analysis of subcellular RNA fractions. Cell 150, 279-290, doi:10.1016/j.cell.2012.05.043 (2012).
33. Ramirez-Carrozzi, V. R. et al. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 138, 114-128, doi:10.1016/j.cell.2009.04.020 (2009).
34. Lu, Y. C., Yeh, W. C. & Ohashi, P. S. LPS/TLR4 signal transduction pathway. Cytokine 42, 145-151, doi:10.1016/j.cyto.2008.01.006 (2008).
35. Hutchins, A. P. et al. Distinct transcriptional regulatory modules underlie STAT3's cell type-independent and cell type-specific functions. Nucleic acids research 41, 2155-2170, doi:10.1093/nar/gks1300 (2013).
36. Diez, D., Hutchins, A. P. & Miranda-Saavedra, D. Systematic identification of transcriptional regulatory modules from protein-protein interaction networks. Nucleic Acids Res 42, e6, doi:10.1093/nar/gkt913 (2014).
37. Hutchins, A. P., Diez, D. & Miranda-Saavedra, D. Genomic and computational approaches to dissect the mechanisms of STAT3's universal and cell type-specific functions. JAKSTAT 2, e25097, doi:10.4161/jkst.25097 (2013).
38. Ogura, H. et al. Interleukin-17 promotes autoimmunity by triggering a positivefeedback loop via interleukin-6 induction. Immunity 29, 628-636, doi:10.1016/j.immuni.2008.07.018 (2008).
39. Dillow, A. F. et al. Temporal Transcriptional Regulation of IL-10-Induced Anti-Inflammatory Genes in LPS-Triggered Macrophages. Open Journal of Immunology 4, 96-116, doi:10.4236/oji.2014.43013 (2014).
40. Murray, P. J. The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proceedings of the National Academy of Sciences of the United States of America 102, 8686-8691, doi:10.1073/ pnas.0500419102 (2005).
41. Hutchins, A. P., Poulain, S. & Miranda-Saavedra, D. Genome-wide analysis of STAT3 binding in vivo predicts effectors of the anti-inflammatory response in macrophages. Blood 119, e110-119, doi:10.1182/blood-2011-09-381483 (2012).
42. El Kasmi, K. C. et al. Cutting edge: A transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway. J Immunol 179, 7215-7219 (2007).
43. Chan, C. S. et al. Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor-alpha translation through a SHIP1-dependent pathway. J Biol Chem 287, 38020-38027, doi:10.1074/jbc.M112.348599 (2012).
44. McCoy, C. E. et al. IL-10 inhibits miR-155 induction by toll-like receptors. J Biol Chem 285, 20492-20498, doi:10.1074/jbc.M110.102111 (2010).
45. Haberman, Y. et al. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest 124, 3617-3633, doi:10.1172/JCI75436 (2014).
46. Ostuni, R. et al. Latent enhancers activated by stimulation in differentiated cells. Cell 152, 157-171, doi:10.1016/j.cell.2012.12.018 (2013).
47. Cahan, P. et al. CellNet: Network Biology Applied to Stem Cell Engineering. Cell 158, 903-915, doi:10.1016/j.cell.2014.07.020 (2014).
48. Boxio, R., Bossenmeyer-Pourie, C., Steinckwich, N., Dournon, C. & Nusse, O. Mouse bonemarrow contains large numbers of functionally competent neutrophils. Journal of leukocyte biology 75, 604-611, doi:10.1189/jlb.0703340 (2004).
49. Dyer, K. D. et al. Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow. J Immunol 181, 4004-4009 (2008).
50. Jensen, B. M., Swindle, E. J., Iwaki, S. & Gilfillan, A. M. Generation, isolation, and maintenance of rodent mast cells and mast cell lines. Current protocols in immunology/edited by John E. Coligan... [et al.] Chapter 3, Unit 3 23 doi:10.1002/0471142735.im0323s74 (2006).
51. Pike, K. A. et al. Protein tyrosine phosphatase 1B is a regulator of the interleukin-10-induced transcriptional program in macrophages. Sci Signal 7, ra43, doi:10.1126/scisignal.2005020 (2014).
52. Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC bioinformatics 12, 323, doi:10.1186/1471-2105-12-323 (2011).
53. Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome biology 10, R25, doi:10.1186/gb-2009-10-3-r25 (2009).
54. Risso, D., Schwartz, K., Sherlock, G. & Dudoit, S. GC-content normalization for RNA-Seq data. BMC bioinformatics 12, 480, doi:10.1186/1471-2105-12-480 (2011).
55. Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome biology 11, R106, doi:10.1186/gb-2010-11-10-r106 (2010).
56. Wilson, D., Charoensawan, V., Kummerfeld, S. K. & Teichmann, S. A. DBD - taxonomically broad transcription factor predictions: new content and functionality. Nucleic acids research 36, D88-92, doi:10.1093/nar/gkm964 (2008).
57. Zhang, H. M. et al. AnimalTFDB: a comprehensive animal transcription factor database. Nucleic acids research 40, D144-149, doi:10.1093/nar/gkr965 (2012).
58. Young, M. D., Wakefield, M. J., Smyth, G. K. & Oshlack, A. Gene ontology analysis for RNA-seq: accounting for selection bias. Genome biology 11, R14, doi:10.1186/gb-2010-11-2-r14 (2010).
59. Zambelli, F., Pesole, G. & Pavesi, G. Pscan: finding over-represented transcription factor binding site motifs in sequences from co-regulated or co-expressed genes. Nucleic Acids Res 37, W247-252, doi:10.1093/nar/gkp464 (2009).
60. Hutchins, A. P., Jauch, R., Dyla, M. & Miranda-Saavedra, D. glbase: a framework for combining, analyzing and displaying heterogeneous genomic and highthroughput sequencing data. Cell Regeneration 3, 1 (2014).